More news
Clinical Cancer Genomics conference, March 20-21 2025, Amsterdam
11-11-2024
We are pleased to announce that registration for this novel exciting meeting focused on cancer whole genome and transcriptome sequencing …
Unraveling of genetic mechanism behind tumor formation may improve targeted treatment for cancer patients
11-08-2022
Genetic alterations in the FGFR2 gene occur in various cancer types and represent a promising target for therapies. However, clinical …
Whole genome sequencing is reliable, has added value, and can be embedded perfectly into everyday pathology diagnostics
10-08-2022
Source: website Netherlands Cancer Institute With the rapidly expanding tableau of (increasingly tumor-agnostic) targeted therapies, genome-driven cancer care has become …
The complete DNA test is an additional tool to help us discover the origin of the cancer in patients with CUP, often enabling us to identify this primary tumor. In addition, the test often reveals new options for targeted treatment.
Nursing specialist